Scholarlink

<p><i>N</i>-palmitoyl-D-glucosamine (PGA) belongs to the class of molecules known as Autacoid Local Injury Antagonism (ALIA)-amides, whose parent compound is <i>N</i>-palmitoyl-ethanolamine (PEA) an endocannabinoid-like mediator belonging to the expanded endocannabinoid system (the endocannabinoidome). The mechanism of action of ALIA-amides is mainly targeted at the down-regulation of the hyperactivity of peripheral mast cells and non-neuronal cells of the central nervous system. This study aimed to investigate if PGA is able to produce the typical “entourage” effect of PEA, consisting of increasing the endogenous levels of the endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG), and to also elevate endogenous PEA levels. PGA (10 µM) treatment of HaCaT cells for 40&#xa0;min and 6&#xa0;h resulted in higher cellular concentrations of AEA, 2-AG and PEA. The increase of endocannabinoid and PEA levels was observed both after 40&#xa0;min and 6&#xa0;h of PGA treatment. The unselective serine hydrolase inhibitor MAFP (10 µM) inhibited the PGA-induced increase in cellular concentrations of AEA, 2-AG and PEA. The mRNA expression of endocannabinoid and PEA anabolic (NAPEPLD, ABHD4, GDE1, DAGLA and DAGLB) and catabolic (FAAH, MAGL and NAAA) enzymes was also measured, revealing a significative reduction of GDE1, DAGLB, FAAH, MAGL and NAAA, after PGA treatment for 6&#xa0;h. Finally, AEA, 2-AG and PEA were also measured in HaCaT cells after siRNA against ABHD4 and PGA treatment for 40&#xa0;min, revealing an increase of their endogenous levels. In conclusion, we demonstrated for the first time that PGA increases PEA and endocannabinoid levels, thus potentially strengthening a part of endocannabinoidome signaling.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Deciphering the interaction between N-palmitoyl-D-glucosamine and the endocannabinoidome

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月1日

查看全文
  • Aniello Schiano Moriello,
  • Marco Allarà,
  • Fabio Arturo Iannotti,
  • Gabriele Marcolongo,
  • Fabiana Piscitelli,
  • Roberta Verde,
  • Vincenzo Di Marzo,
  • Stefania Petrosino

摘要

N-palmitoyl-D-glucosamine (PGA) belongs to the class of molecules known as Autacoid Local Injury Antagonism (ALIA)-amides, whose parent compound is N-palmitoyl-ethanolamine (PEA) an endocannabinoid-like mediator belonging to the expanded endocannabinoid system (the endocannabinoidome). The mechanism of action of ALIA-amides is mainly targeted at the down-regulation of the hyperactivity of peripheral mast cells and non-neuronal cells of the central nervous system. This study aimed to investigate if PGA is able to produce the typical “entourage” effect of PEA, consisting of increasing the endogenous levels of the endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG), and to also elevate endogenous PEA levels. PGA (10 µM) treatment of HaCaT cells for 40 min and 6 h resulted in higher cellular concentrations of AEA, 2-AG and PEA. The increase of endocannabinoid and PEA levels was observed both after 40 min and 6 h of PGA treatment. The unselective serine hydrolase inhibitor MAFP (10 µM) inhibited the PGA-induced increase in cellular concentrations of AEA, 2-AG and PEA. The mRNA expression of endocannabinoid and PEA anabolic (NAPEPLD, ABHD4, GDE1, DAGLA and DAGLB) and catabolic (FAAH, MAGL and NAAA) enzymes was also measured, revealing a significative reduction of GDE1, DAGLB, FAAH, MAGL and NAAA, after PGA treatment for 6 h. Finally, AEA, 2-AG and PEA were also measured in HaCaT cells after siRNA against ABHD4 and PGA treatment for 40 min, revealing an increase of their endogenous levels. In conclusion, we demonstrated for the first time that PGA increases PEA and endocannabinoid levels, thus potentially strengthening a part of endocannabinoidome signaling.